SCHEMBL722331

SCHEMBL722331

[Co].c1cnc2c(c1)ccc1ncccc12.c1cnc2c(c1)ccc1ncccc12

nearest known ligand 0.96

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.96
CYP3A4 P08684 2/20 0.64
CCR1 P32246 5/20 0.60
CCR8 P51685 5/20 0.60
MAPT P10636 3/20 0.60
HSP90AA1 P07900 3/20 0.60
CCR5 P51681 3/20 0.60
KDM4E B2RXH2 2/20 0.60
HTT P42858 2/20 0.60
HIF1A Q16665 2/20 0.60
MMP2 P08253 2/20 0.60
TSHR P16473 2/20 0.60
GMNN O75496 1/20 0.60
TP53 P04637 1/20 0.60
CYP2D6 P10635 1/20 0.60
MMP9 P14780 1/20 0.60
ALOX15 P16050 1/20 0.60
NFKB1 P19838 1/20 0.60
MMP8 P22894 1/20 0.60
THPO P40225 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL249178 1.00 LMNA (0.96) LMNACYP3A4CCR1CCR8MAPT
SCHEMBL723791 1.00 LMNA (0.96) LMNACYP3A4CCR1CCR8MAPT
SCHEMBL6513577 0.98 LMNA (1.00) LMNACYP3A4CCR1CCR8MAPT
SCHEMBL8313 0.98 LMNA (1.00) LMNACYP3A4CCR1CCR8MAPT
SCHEMBL1052095 0.96 LMNA (0.96) LMNACYP3A4CCR1CCR8MAPT
SCHEMBL15788918 0.96 LMNA (0.96) LMNACYP3A4CCR1CCR8MAPT
Hydrochloric Acid SCHEMBL4917361 0.96 LMNA (0.96) LMNACYP3A4CCR1CCR8MAPT
Iodide SCHEMBL10638043 0.96 LMNA (0.96) LMNACYP3A4CCR1CCR8MAPT
SCHEMBL7268962 0.96 LMNA (0.96) LMNACYP3A4CCR1CCR8MAPT
SCHEMBL3885158 0.96 LMNA (0.96) LMNACYP3A4CCR1CCR8MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9157884-B2 Method for electrochemically detecting target substance, method for electrochemically detecting analyte, and detection set SYSMEX CORPORATION (JP) 2015-10-13 US disclosed
EP-2515112-B1 Method for electrochemically detecting analyte SYSMEX CORP (JP) 2015-08-12 EP disclosed
US-20140371082-A1 PROCESS AND APPARATUS FOR QUANTIFYING NUCLEIC ACID IN A SAMPLE BIOQUANTA SA (FR) 2014-12-18 US disclosed
US-20120267258-A1 METHOD FOR ELECTROCHEMICALLY DETECTING ANALYTE NARA INSTITUTE OF SCIENCE AND TECHNOLOGY (JP) 2012-10-25 US disclosed
EP-2515112-A2 Method for electrochemically detecting analyte SYSMEX CORPORATION (JP) 2012-10-24 EP disclosed
US-20120048747-A1 METHOD FOR ELECTROCHEMICALLY DETECTING TARGET SUBSTANCE, METHOD FOR ELECTROCHEMICALLY DETECTING ANALYTE, AND DETECTION SET SYSMEX CORPORATION (JP) 2012-03-01 US disclosed
US-20090036315-A1 Device and methods for detecting and quantifying one or more target agents ANTARA BIOSCIENCES INC. (US) 2009-02-05 US disclosed
EP-1146331-B1 GENE DETECTING CHIP, DETECTOR, AND DETECTING METHOD TAKENAKA SHIGEORI (JP) 2008-09-10 EP disclosed
US-20080026394-A1 Methods of detecting one or more cancer markers ANTARA BIOSCIENCES INC. (US) 2008-01-31 US disclosed
US-6916614-B1 For detecting and analyzing genetic abnormalities such as DNA single base substitution SNP (single nucleotide polymorphism), plural base substitution, point mutation, and genetic loss as well as addition of base sequences in genes TUM GENE, INC. (JP) 2005-07-12 US disclosed
US-6864055-B2 Method for detecting nucleic acids FUJI PHOTO FILM CO., LTD. (JP) 2005-03-08 US disclosed
US-20040152097-A1 using solid phase synthesis for quantitative analysis with high sensitivity and enhanced throughput; genetic engineering TOPPAN PRINTING CO., LTD. (JP) 2004-08-05 US disclosed
US-20040152085-A1 Surface for collection and/or purification of nucleic acids VERIDIAN SYSTEMS DIVISION 2004-08-05 US disclosed
US-20020076717-A1 Method for detecting nucleic acids FUJI PHOTO FILM CO., LTD. (JP) 2002-06-20 US disclosed
US-20010053522-A1 DNA chip and reactive electrode FUJI PHOTO FILM CO., LTD. 2001-12-20 US disclosed
EP-1146331-A1 GENE DETECTING CHIP, DETECTOR, AND DETECTING METHOD Takenaka, Shigeori (JP) 2001-10-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020076717-A1 Method for detecting nucleic acids POLRMT, DNMT1, POLN LMNA 440/4885CYP3A4 4526/4885CCR1 3781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.